Ellagitannins in Plant-Based Foods

Ellagitannins are large hydrolysable polyphenolic compounds found predominantly in plant-based foods, particularly pomegranate, berries (raspberries, strawberries, blackberries), walnuts, and chestnuts. Pomegranate juice contains the highest concentration at approximately 3,000 mg/100ml, while whole pomegranate averages ~2,500 mg/100g. Raspberries provide ~87 mg/100g, and cloudberries ~83 mg/100g. Ellagitannins are highly distinctive to plants; animal products contain negligible amounts.

When consumed, ellagitannins are hydrolysed in the gastrointestinal tract and converted by gut microbiota into bioavailable urolithins — metabolites with potent anti-inflammatory and antioxidant properties.

Pomegranate is the most concentrated dietary source of ellagitannins due to its botanical physiology and tannin accumulation strategy. Pomegranate arils (seeds) contain structural ellagitannins — high-molecular-weight polyphenols that serve as plant defence compounds against pathogens and herbivores.

The fruit's pericarp (rind) and juice contain exceptionally high concentrations: pomegranate juice alone contains ~3,000 mg ellagitannins per 100ml. This concentration results from the fruit's cellular tannin production during development and ripening. Pomegranate juice retains most of these compounds through processing, making it an exceptionally bioavailable source. In contrast, whole pomegranate (including arils and surrounding tissue) contains ~2,500 mg/100g, slightly lower due to dilution from structural tissue.

Urolithins are bioactive metabolites produced when ellagitannins and ellagic acid from plant foods are metabolised by the human gut microbiota. Ellagitannins are too large to be directly absorbed; instead, they are hydrolysed in the small intestine to ellagic acid, which is further metabolised by colonic bacteria into a series of urolithin metabolites (designated urolithin A, B, C, and D).

This gut-derived conversion is essential because urolithins — not the parent ellagitannins — cross the intestinal barrier and accumulate in tissues. Urolithins have demonstrated anti-inflammatory, antioxidant, and mitochondrial-protective effects. They reduce pro-inflammatory cytokine production, enhance cellular antioxidant defences, and improve mitochondrial biogenesis and metabolic health. Some evidence suggests urolithin metabolites support muscle strength and healthy ageing. Importantly, urolithin production is highly individual and depends on gut microbiota composition and function — genetic background, diet, and antibiotic use influence whether an individual efficiently converts ellagitannins to active urolithin metabolites.

Raspberries are the highest in ellagitannins among berries, providing ~87 mg/100g. Cloudberries (also called Arctic berries) contain ~83 mg/100g, and strawberries provide ~79 mg/100g. Blackberries deliver ~36 mg/100g, while boysenberries contain ~17 mg/100g. Blueberries, despite being nutrient-dense, contain lower ellagitannin concentrations.

Raspberries and blackberries share a botanical advantage: the aggregate fruit structure (composed of many small drupelets) creates multiple tannin-accumulating cells, concentrating ellagitannins in the fruit wall. Fresh berries retain most of their ellagitannin content; frozen berries preserve these compounds well. Dried raspberries and berries can concentrate ellagitannins further, making them potent additions to smoothies, cereals, and plant-based desserts.

Ellagitannin-rich foods, particularly pomegranate and berries, are associated with numerous health benefits in human and animal studies. Their urolithin metabolites provide anti-inflammatory effects — reducing systemic inflammation markers such as TNF-α, IL-6, and NF-κB signalling. Antioxidant mechanisms involve upregulating endogenous antioxidant enzymes (SOD, catalase, glutathione peroxidase) and scavenging reactive oxygen species.

Cardiovascular benefits include improved endothelial function, reduced arterial stiffness, and improved lipid profiles. Some evidence suggests urolithins support mitochondrial function and biogenesis, potentially enhancing cellular energy production and supporting healthy ageing. Preliminary research indicates links to improved muscular strength in older adults. Additionally, ellagitannins and their metabolites exhibit antimicrobial and prebiotic properties — selectively supporting beneficial bacterial growth in the microbiota.

Yes — ellagitannins are remarkably stable during juice processing and actually concentrate in pomegranate juice compared to whole fruit. Cold-pressed and pasteurised pomegranate juices retain 85–95% of original ellagitannin content. Heat treatment (pasteurisation) does not significantly degrade ellagitannins; in fact, moderate heating can increase extractability by breaking down cell walls.

Commercial pomegranate juice, whether cold-pressed or pasteurised, delivers ~2,800–3,000 mg/100ml, comparable to fresh juice. This stability contrasts with some other polyphenols (anthocyanins, vitamin C) which are more heat-sensitive. However, extended storage at room temperature or in warm conditions may gradually reduce ellagitannin levels. Fresh pomegranate juice, consumed immediately after juicing, provides maximum ellagitannin bioavailability. For long-term storage, frozen pomegranate juice preserves ellagitannins better than ambient-temperature storage.

Gut microbiota composition is the primary determinant of ellagic acid conversion to urolithins — and this relationship explains substantial individual variation in ellagitannin health benefits. The production of urolithins requires a consortium of bacterial species: Faecalibacterium prausnitzii, Bacteroides ovatus, and other members of the Bacteroidaceae and Lachnospiraceae families initially hydrolyse ellagic acid and produce intermediate metabolites; downstream bacteria then convert these intermediates to different urolithin isomers (urolithin A, B, C, D).

Individuals harbouring these bacterial lineages efficiently produce bioactive urolithins; those lacking these species produce little to no urolithin metabolites — a phenomenon termed the "metabotype" system. Microbiota diversity is crucial: broader bacterial diversity correlates with better capacity to convert ellagitannins. Factors influencing urolithin production include antibiotic history (antibiotics deplete these bacterial lineages), dietary pattern (high-fibre diets support bacterial abundance), age, and genetics. Some individuals are "urolithin responders" producing high levels; others are "non-responders." Prebiotic interventions (inulin, FOS) can increase bacterial populations capable of urolithin synthesis, potentially improving conversion efficiency over weeks to months.

Yes — walnuts are a significant plant-based source of ellagitannins, providing ~59 mg/100g. Unlike berries and pomegranate where ellagitannins are the primary polyphenol, walnuts contain a diverse polyphenol profile dominated by hydrolysable tannins (including ellagitannins). The ellagitannin and ellagic acid content in walnuts remains stable during storage and is resistant to oxidation, making walnuts a consistent year-round source. Walnuts also provide complementary omega-3 fatty acids (ALA, α-linolenic acid), which support cardiovascular and cerebral health in synergy with the ellagitannins.

A single ounce of walnuts (~28g) delivers approximately 16 mg ellagitannins. Chestnuts (~24 mg/100g) are another nut source, though typically consumed less frequently. Combining walnuts with berries and pomegranate creates a potent plant-based dietary strategy for optimising ellagitannin intake across multiple food groups.

Ellagic acid, ellagitannins, and urolithins represent sequential compounds in the ellagitannin metabolism pathway, each with distinct chemical structure and bioactivity. Ellagitannins are large hydrolysable tannin polymers (molecular weight 600–3000+ Da) found intact in plant foods; they are poorly bioavailable because they are too large to be absorbed by the small intestine. When consumed, ellagitannins undergo enzymatic hydrolysis in the gastrointestinal tract, releasing ellagic acid — a smaller C-15H8O8 polyphenolic compound found in concentrated form in pomegranate and berries. Ellagic acid itself exhibits antioxidant properties and some direct bioactivity, but the majority is not absorbed in the small intestine.

Instead, ellagic acid reaches the colon where it is metabolised by the gut microbiota through a series of enzymatic steps into urolithins — smaller, structurally distinct C13 metabolites (urolithins A, B, C, D). Urolithins cross the intestinal barrier, circulate systemically, and accumulate in tissues where they exert anti-inflammatory, antioxidant, and mitochondrial-protective effects. In summary: ellagitannins (plants) → ellagic acid (hydrolysis) → urolithins (microbial metabolism) → systemic bioactivity.